National Comprehensive Cancer Network

About NCCN

NCCN eBulletin Newsletter

NCCN eBulletin Newsletter – Archived Issues

February 11, 2013 | Volume 5 Issue 4

• NCCN Trends™: An Evaluation of the Use of Companion Diagnostic Testing and Targeted Therapies
• NCCN Guidelines for Patients^®: Breast Cancer Now Available in Portuguese
• NCCN Guidelines and Compendium Updated

January 28, 2013 | Volume 5 • Issue 3

• New NCCN Guidelines for Patients^® Available for Adolescents and Young Adults with Cancer
• An Update on NCCN/NBGH Initiative to Develop Evidence-Based Cancer Treatment Recommendations: Year 3
• Coming Soon! NCCN Trends™ Survey Highlights
• NCCN Guidelines and Compendium Updated

January 14, 2013 | Volume 5 • Issue 2

• NCCN Qualifies Community Site for Affiliate Research Project
• NCCN Leader Elected as a Master of the American College of Physicians
• New NCCN Guidelines Translations Available
• Patient Advocacy Summit Summary Now Available
• NCCN Guidelines and Compendium Updated

January 7, 2013 | Volume 5 • Issue 1

• The National Comprehensive Cancer Network Welcomes Dr. Robert Carlson as Chief Executive Officer

December 10, 2012 | Volume 4 • Issue 25

• NCCN Biomarkers Compendium™ Now Available
• The National Comprehensive Cancer Network,The US Oncology Network, and McKesson Specialty Health Collaborate to Offer New Value Pathways for Cancer Care
• NCCN Guidelines and Compendium Updated

November 26, 2012 | Volume 4 • Issue 24

• New Translations of NCCN Guidelines Available
• NCCN Guidelines and Compendium Updated

November 12, 2012 | Volume 4 • Issue 23

• NCCN Pocket Guidelines Available for FREE
• NCCN to Hold Patient Advocacy Summit
• NCCN Guidelines and Compendium Updated

November 2, 2012 | Volume 4 • Issue 22

• NCCN Equity White Paper Published
• NCCN Guidelines and Compendium Updated

October 15, 2012 | Volume 4 • Issue 21

• NCCN Holds Data Needs Policy Summit
• Researchers Receive Grants from NCCN Oncology Research Program Funded through AVEO/Astellas Collaboration
• A Candid Discussion with Amanda Bennett to Start the NCCN 18^th Annual Conference
• NCCN Guidelines and Compendium Updated

October, 1, 2012 | Volume 4 • Issue 20

• NCCN Appoints Dr. Robert Carlson as CEO
• NCCN and McKesson Specialty Health Collaborate to Provide Clinical Decision-Support Tool
• Growth and Transition for the NCCN Foundation
• New NCCN Guidelines Virtual Library Available for iPad
• NCCN Guidelines and Compendium Updated

September 17, 2012 | Volume 4 • Issue 19

• NCCN 7th Annual Congress: Hematologic Malignancies
• NCCN Plans Release of Biomarkers Compendium
• Academy Video Modules Available
• Researchers Receive Grants from NCCN Oncology Research Program Funded through GlaxoSmithKline
• NCCN Guidelines and Compendium Updated

September 4, 2012 | Volume 4 • Issue 18

• NCCN Informed Consent Language Database Now Available on NCCN.org
• NCCN to Hold Inaugural General Poster Session at Annual Conference
• New Pancreatic Cancer Guidelines for Patients Available from NCCN
• Researchers Receive Grants from NCCN Oncology Research Program Funded through Boehringer Ingelheim
• NCCN Guidelines and Compendium Updated

August 20, 2012 | Volume 4 • Issue 17

• An Update on NCCN/NBGH Initiative to Develop Evidence-Based Cancer Treatment Recommendations
• Josh Bilenker, MD, Former FDA Medical Officer and Partner at Aisling Capital, Named to NCCN Foundation Board
• New Japanese Translations of the NCCN Guidelines Available
• NCCN Academy Examines Healthcare Reform and Innovations in Oncology
• NCCN Guidelines and Compendium Updated

August 6, 2012 | Volume 4 • Issue 16

•  NCCN Academy Examines Healthcare Reform and Innovations in Oncology
•  NCCN Virtual Reimbursement Resource Room
• NCCN Guidelines and Compendium Updated

July 23, 2012 | Volume 4 • Issue 15

• New Lung Cancer Screening Guidelines for Patients Available from NCCN
• NCCN Qualifies First Community Sites for Affiliate Research Project
• NCCN Guidelines and Compendium Updated

July 9, 2012 | Volume 4 • Issue 14

• NCCN Research at the 2012 ASCO Annual Meeting Focused on ALK and MET Expression in Glioblastoma Multiforme
• Supreme Court Upholds Affordable Care Act
• 2012 ASCO Abstract Highlights Operational Aspects of Genetic Counseling Programs
• NCCN Guidelines and Compendium Updated

June 25, 2012 | Volume 4 • Issue 13

• NCCN Research Presented at ASCO
• 2012 ASCO Poster Highlights NCCN Research
• NCCN Guidelines and Compendium Updated

June 11, 2012 | Volume 4 • Issue 12

• IOM and CMTP Hold Molecular Diagnostics Workshop
• Highlights of the NCCN 17^th Annual Conference Now Available
• NCCN Guidelines and Compendium Updated

May 29, 2012 | Volume 4 • Issue 11

• NCCN Holds Equity Policy Summit
• NCCN Foundation Announces 2012 Young Investigator Awards
• NCCN Guidelines and Compendium Updated

May 14, 2012 | Volume 4 • Issue 10

• Clinical Trials as an Option: NCCN Trends™ Survey
• JNCCN — Journal of the National Comprehensive Cancer Network Introduces the New NCCN Guidelines^® Insights
• NCCN Guidelines and Compendium Updated

April 30, 2012 | Volume 4 • Issue 9

• Ellen Tauscher, Former Under Secretary of State for Arms Control and International Security and Member of Congress, Named to NCCN Foundation Board
• Data Needs: Assessing Guidance, Endpoints, and Patient-Reported Outcomes in Oncology Clinical Care
• NCCN Guidelines and Compendium Updated

April 16, 2012 | Volume 4 • Issue 8

• Highlights of the NCCN 17th Annual Conference
• NCCN Roundtable: Challenges in Optimal Care for Patients
• Fellows Program at NCCN 17th Annual Conference
• Oncology Pathways and Perceptions of Impact in Cancer Care
• NCCN Guidelines and Compendium Updated

April 2, 2012 | Volume 4 • Issue 7

• NCCN Opens 17^th Annual Conference with Roundtable Discussion on Cancer Care and Corporate America
• 2012 Pharmacy Program Covered a Number of Topics Integral to Pharmacists
• NCCN Nursing Program: Advancing Oncology Nursing
• NCCN Guidelines and Compendium Updated

March 19, 2012 | Volume 4 • Issue 6

• Coming soon! Updates from the NCCN 17th Annual Conference
• NCCN Guidelines and Compendium Updated

March 5, 2012 | Volume 4 • Issue 5

• FDA Releases Draft Guidance on Biosimilars
• New! Health Technology Row at the NCCN 17th Annual Conference
• NCCN Guidelines and Compendium Updated

February 21, 2012 | Volume 4 • Issue 4

• NCCN.org – New Look, Same Quality Content
• An Update on NCCN/NBGH
• New NCCN Translations
• NCCN Guidelines and Compendium Updated

February 6, 2012 | Volume 4 • Issue 3

• Clifford Goodman to Moderate March NCCN Academy
• Setting the Guidelines for Cancer Treatment in the Middle East & North Africa
• 2012 NCCN Policy Summits
• NCCN Guidelines and Compendium Updated

January 23, 2012 | Volume 4 • Issue 2

• NCCN Nursing Program: Advancing Oncology Nursing
• Gynecologic Malignancies Added to Compilation of Japanese Translations
• 2012 NCCN Oncology Pharmacy Program: Supportive Care, New Drugs and Biologics, Oral Chemotherapeutic Compliance, and Pharmacy Interventions
• NCCN Guidelines and Compendium Updated

January 9, 2012 | Volume 4 • Issue 1

• A note from the editorial team
• NCCN Highlights from 2011
• NCCN Guidelines for Patients™ for Prostate Cancer
• NCCN Pocket Guidelines Available for FREE
• NCCN Guidelines and Compendium Updated

December 12, 2011 | Volume 3 • Issue 24

• NCCN Holds Patient Advocacy Summit
• NCCN Education Program for Case Managers Successful in Its Sixth Year and Planning for 2012
• This Thursday: What You Always Wanted to Know About NCCN
• NCCN Guidelines and Compendium Updated

November 28, 2011 | Volume 3 • Issue 23

• NCCN Hosts Pharmacy Best Practices Congress

• NCCN Guidelines for Patients Available in Print Booklet Format
• NCCN Guidelines for Patients for Melanoma Updated

• NCCN Guidelines and Compendium Updated

November 14, 2011 | Volume 3 • Issue 22

• NCCN Announces New Addition to Library of Guidelines: NCCN Guidelines for Lung Cancer Screening

• NCCN Receives $2 Million in Oncology Research Funding from Boehringer Ingelheim to Investigate Afatinib in Solid Tumors

• NCCN Guidelines and Compendium Updated

October 31, 2011 | Volume 3 • Issue 21

• NCCN Meeting More Educational Needs in the Oncology Community with New Learning Management System
• NCCN 2011 Congress Series: Genitourinary Cancers™ Highlights
• NCCN Hosts 2011 Congress Series: Gastrointestinal Cancers™
• Jai Pausch Speaks to the Value of In-Person Visits to a Loved One with Cancer in Latest NCCN.com Column
• NCCN Guidelines and Compendium Updated

October 17, 2011 | Volume 3 • Issue 20

• NCCN Receives $4 Million in Oncology Research Funding from GlaxoSmithKline
• Optimal Regimen in Maintenance Therapy for Multiple Myeloma Remains Unclear According to NCCN Expert
• Coming Soon: The NCCN 17th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™
• NCCN Guidelines and Compendium Updated

October 3, 2011 | Volume 3 • Issue 19

• NCCN Guidelines Emphasize Patient Preference as Key to Selection of Maintenance Therapy in Follicular Lymphoma
• NCCN Experts and Asian Oncologists Collaborate to Develop Resources to Improve Care for Patients with Cancer in China
• On the Horizon for the NCCN Foundation
• Kimary Kulig, PhD, MPH, Joins NCCN Staff as Vice President, Clinical & Translational Outcomes Research
• NCCN Guidelines and Compendium Updated

September 19, 2011 | Volume 3 • Issue 18

• NCCN 6th Annual Congress: Hematologic Malignancies
• Advances in CLL Therapy Offer Prolonged Survival; Toxicities Continue to Plague Elderly Patients
• NCCN Expert Discusses Extending Life-Saving Pediatric Treatments to Adults with Acute Lymphoblastic Leukemia
• An Update on NCCN/NBGH Initiative to Develop Evidence-Based Cancer Treatment Recommendations
• NCCN Guidelines and Compendium Updated

September 6, 2011 | Volume 3 • Issue 17

• Researchers Receive Grants from NCCN Oncology Research Program Funded Through GlaxoSmithKline
• NCCN Guidelines and Compendium Updated

August 22, 2011 | Volume 3 • Issue 16

• NCCN Receives $2M Educational Grant from Pfizer to Support Tailored Quality Improvement Plans at Leading Cancer Centers
• NCCN on the Global Stage: International Adaptations & Translations of the NCCN Guidelines Available
• NCCN Guidelines and Compendium Updated

August 8, 2011 | Volume 3 • Issue 15

• NCCN Holds Molecular Testing Summit
• NCCN and Experts from China Collaborate to Develop Colon, Kidney, Non-Small Cell Lung, and Ovarian Cancer Guidelines, China Editions
• NCCN Continues Ad Campaign with U.S. News & World Report
• New NCCN Patient Guidelines Help Patients Navigate the Maze of Breast Cancer Treatment Options
• NCCN Guidelines and Compendium Updated

July 25, 2011 | Volume 3 • Issue 14

• Latin America Welcomes Back NCCN
• NCCN Accredited by the ACPE to Provide Continuing Pharmacy Education
• NCCN Guidelines and Compendium Updated

July 11, 2011 | Volume 3 • Issue 13

• Researchers Receive Grants from NCCN Oncology Research Program Funded Through Pfizer

• New Malignant Pleural Mesothelioma Guidelines for Patients Available from NCCN

• NCCN Guidelines and Compendium Updated

June 27, 2011 | Volume 3 • Issue 12

• NCCN Launches NCCNChina.org, a Valuable Online Resource for the Chinese Oncology Community

• Check out NCCN on Facebook
• 30-Day Free Preview of the NCCN Chemotherapy Order Templates
• NCCN Guidelines and Compendium Updated

June 13, 2011 | Volume 3 • Issue 11

• More Than 600 NCCN Chemotherapy Order Templates Now Available from NCCN to Enhance Patient Safety

• Andrew von Eschenbach Named to NCCN Foundation Board
• New Chronic Myelogenous Leukemia Guidelines for Patients Available from NCCN
• 2011 ASCO Poster Presentation Highlights NCCN Research
• NCCN Guidelines and Compendium Updated

May 31, 2011 | Volume 3 • Issue 10

• HHS Unveils Proposed New Rules for Accountable Care Organizations
• An Update on NCCN/NBGH Initiative to Develop Evidence-Based Cancer Treatment Recommendations
• More Oncology Drug Shortages
• NCCN Advances Oncology Imaging Research through the NCCN Specialized Imaging Research Consortium
• NCCN Guidelines and Compendium Updated

May 16, 2011 | Volume 3 • Issue 9

• NCCN Holds Biosimilars Policy Summit
• Opioid REMS Will Focus on Educating Prescribers
• PET Imaging in Breast, Non-Small Cell Lung, and Prostate Cancer
• NCCN Foundation Announces Young Investigators Awards
• Jai Pausch Addresses Fear and Anxiety in the Aftermath of Cancer Treatment

• NCCN Guidelines Updated

May 2, 2011 | Volume 3 • Issue 8

• NCCN 4th Annual Asia Scientific Congress Held in Shanghai, China
• NCCN Hematologic Malignancies Congress Aims to Further Treatment in China
• Molecular Marker Testing in Oncology: What Information is Important?

• NCCN Guidelines Updated

April 18, 2011 | Volume 3 • Issue 7

• Biosimilars: More Education Is Needed
• The Hematology/Oncology Pharmacy Association Annual Conference: Seven Years of Educating Oncology Pharmacists
• NCCN and Society of Nuclear Medicine Join to Advance Oncology Imaging Research
• Coming Soon to NCCN.com! “The Many Faces and Challenges of Caregivers” Roundtable Video Hosted by Sam Donaldson
• NCCN Guidelines and Compendium Updated

April 4, 2011 | Volume 3 • Issue 6

• NCCN Panel Calls for Higher Standards, Better Ways of Translating Molecular Genetics into Clinical Practice
• Post-Transplant Lymphoproliferative Disorder Section Integrated into Updated NCCN Guidelines for NHL
• Second-Line TKIs Offer Expanded Treatment Options for Newly Diagnosed Patients with CML
• New Treatment Options Lead to Steady Progress Against Ovarian Cancer; Clinical Trials Remain Imperative
• Active Surveillance Monitoring More Stringent in Updated NCCN Guidelines for Prostate Cancer
• NCCN Oncology Policy Summit: Biosimilars – Regulatory, Scientific, and Patient Safety Perspectives
• JNCCN Supplements Now Available
• NCCN Guidelines and Compendium Updated

March 21, 2011 | Volume 3 • Issue 5

• Nursing Program Stresses a Multidisciplinary Approach to Cancer Care
• REMS, Biomarkers, and New Therapies Were Discussed by Pharmacists at the NCCN Annual Conference
• NCCN Fellows Recognition Program Demonstrates the Promise of a New Generation of Oncologists
• NCCN Roundtable Addresses the Many Faces and Challenges of Caregivers
• 'The Coach and the Critic: Stories of Caregivers Where 'Kill Me' Is Not an Option'
• New Therapies for Metastatic Disease Addressed in Updated NCCN Guidelines for Breast Cancer
• NCCN Reimbursement Resource Room Helps Mitigate Reimbursement Challenges
• Jai Pausch Advises Caregivers to Balance Urgency for Care with Thoughtful Treatment Decisions in NCCN.com Column
• NCCN Guidelines and Compendium Updated

February 22, 2011 | Volume 3 • Issue 4

• Keeping Current: Why State Laws Must Keep Pace with CMS
• Russell W. Budd Named to NCCN Foundation Board
• NCCN Oncology Pharmacy Program Discusses REMS, Biomarkers, and New Drugs
• New Modules Added to Upcoming NCCN Academy
• Watch for Updates from the NCCN 16th Annual Conference
• NCCN Flash Update: NCCN Guidelines for Non-Hodgkin's Lymphomas Updated

February 7, 2011 | Volume 3 • Issue 3

• Coping with Drug Shortages
• Jai Pausch Addresses Caregiver Concerns in New NCCN Column
• NCCN REMS Resource Webpage Updated
• NCCN Facebook Page Launched
• NCCN Guidelines and Compendium Updated

January 24, 2011 | Volume 3 • Issue 2

• The Avastin Question and the Payor Community
• Jai Pausch to Address Caregiver Concerns in New NCCN Column
• Caregiving in Cancer Focus of Annual NCCN Roundtable
• Policy Summits
• NCCN Reimbursement Resource Room
• NCCN Guidelines and Compendium Updated

January 10, 2011 | Volume 3 • Issue 1

• NCCN/NBGH Initiative to Develop Evidence-Based Cancer Treatment Recommendations for Large Employers
• Melanoma, Ovarian, and Prostate Cancer Treatment Guidelines for Patients Now Available
• NCCN Academy Video Modules Available for Training
• Coordinating Office Established to Advance MENA/NCCN Collaboration
• NCCN Flash Update: NCCN Guidelines^®

December 13, 2010 | Volume 2 • Issue 25

• New Multiple Myeloma Treatment Guidelines for Patients Available from NCCN
• A Year in Review
• NCCN Welcomes Chronic Myelogenous Leukemia Clinicians from China
• Molecular Marker Testing Dialogue Continues at ASH
• New NCCN Program Recognizes Organizations Supporting Coverage for Clinical Trials and Appropriate Off-Label Drug Usage
• NCCN Guidelines and NCCN Compendium Updated

November 29, 2010 | Volume 2 • Issue 24

• Financial Impact of the 2011 Medicare Physician Fee Schedule, an SGR Fix, and the Federal Debt Commission
• Biosimilars: What Can Clinicians Expect?
• Improving Patients' Understanding of Cancer
• NCCN Oncology Research Program: Advancing Care Through Clinical Research
• NCCN in the Middle East and North Africa (MENA): Developing Resources and Relationships
• NCCN Guidelines for Cervical Cancer Updated

November 15, 2010 | Volume 2 • Issue 23

• PDUFA Reauthorization: How Does This Affect REMS?
• NCCN Collaborates to Alleviate Adult Cancer Pain in China
• NCCN Oncology Summit: Compendia Use for Off-Label Indications
• NCCN Guidelines for Breast Cancer Updated

November 1, 2010 | Volume 2 • Issue 22

• NCCN Holds Patient Safety Summit
• Commentary – Cancer Clinical Trials: A Delicate Balancing Act
• NCCN Trends™ Survey and Data: EGFR Mutation Testing Practices

• NCCN Guidelines and NCCN Compendium Updated for Colon Cancer, Rectal Cancer, and Anal Carcinoma

October 18, 2010 | Volume 2 • Issue 21

• NCCN Guidelines for Breast Cancer Updated; Bevacizumab Recommendation Affirmed
• Improving Safety for Patients with Cancer; NCCN Safety Summit Features Peter Pronovost, MD, PhD
• What's New With REMS?
• NCCN 5th Annual Congress: Hematologic Malignancies

• NCCN Guidelines^® and NCCN Compendium^® for Acute Myeloid Leukemia

October 4, 2010 | Volume 2 • Issue 20

• NCCN Announces the NCCN Guidelines for Patients™
• NCCN Holds Patient Advocacy Summit
• Commentary – Patient Protection and Affordable Care Act Takes Effect
• Special Edition of JNCCN Now Available
• NCCN Flash Update: NCCN Guidelines^® and NCCN Compendium^® Updated

September 20, 2010 | Volume 2 • Issue 19

• NCCN Covers New Ground in Gramado
• Compendia Usage and Off-Label Indications Focus on NCCN Oncology Summit
• NCCN Oncology Policy Summits: Comparative Effectiveness Report Published
• NCCN Guidelines and NCCN Compendium for Prostate Cancer Updated

September 7, 2010 | Volume 2 • Issue 18

• Commentary - Access to Cancer Care in the Era of Restricted Provider Networks
• New Addition to the Complete Library of NCCN Guidelines
• NCCN Compendium^® Chapter for Chronic Myelogenous Leukemia (CML) Updated

August 23, 2010 | Volume 2 • Issue 17

• Physicians Reference the NCCN Guidelines First, According to QuantiaMD Survey
• NCCN Trends International Surveys Now Available on NCCN.org
• Managing Hematologic Malignancies Is Increasingly Complex
• NCCN Guidelines and NCCN Compendium for Acute Myeloid Leukemia Updated

August 9, 2010 | Volume 2 • Issue 16

• NCCN Receives $4 Million in Oncology Research Funding from GlaxoSmithKline
• Radiation Safety a Priority at Johns Hopkins
• Managed Care Organizations to Focus on Value in Oncology
• NCCN Guidelines and NCCN Compendium for Cancer- and Chemotherapy-Induced Anemia Updated

July 26, 2010 | Volume 2 • Issue 15

• NCCN and Proventys to Launch Novel Decision Support System
• NCCN Answers a Need in Latin America
• Nearly Half of Clinicians Likely to Use New Therapy for Prostate Cancer
• FDA Responds to Public Concerns and Reconsiders REMS Elements
• NCCN Guidelines and NCCN Compendium for Prostate Cancer Updated

July 12, 2010 | Volume 2 • Issue 14

• NCCN Guideline Translations on NCCN.org
• Commentary – Quality and Value Initiatives in Health Reform
• Will the CML Treatment Paradigm Change Again?
• New Features Simplify Navigation of NCCN Virtual Reimbursement Resource Room
• NCCN Guidelines^® and NCCN Compendium^® Updated

June 28, 2010 | Volume 3 • Issue 13

• NCCN Draft REMS White Paper Now Available for Comment on NCCN.org
• Commentary – NCCN Analytics, Research and Consulting
• NCCN Names New Foundation Board Members
• NEW: Downloads of Free NCCN Guidelines Mobile Apps for Android and iPhone Rising
• NCCN Compendium Chapters for Central Nervous System Tumors (CNS) Updated

June 14, 2010 | Volume 2 • Issue 12

• NCCN Survey Reveals Opportunities for Improving Clinical Trial Accruals
• 2010 ASCO Poster Presentations Highlight NCCN Research
• NCCN Physicians Present Studies Funded by the NCCN Oncology Research Program at ASCO
• NCCN Launches Free NCCN Guidelines Mobile App for Android (iPhone Coming Soon!)
• NCCN Compendium^® Chapter for Non-Small Cell Lung Cancer Updated
• Response to Preoperative Therapy May Predict Survival in Pancreatic Cancer Patients (Fox Chase Cancer Center)
• Nanoparticle PSA Test Predicts if Prostate Cancer Will Return (Robert H. Lurie Comprehensive Cancer Center at Northwestern University)
• Bone Drug Suppresses Wandering Tumor Cells in Breast Cancer Patients (Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine)
• Common Berries Fight Cancer As Well As Exotic Varieties (The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research Institute)

June 1, 2010 | Volume 2 • Issue 11

• Clinicians Face Challenges in the Management of Cancer-Related Anemia
• Implementation of Health Reform in 2010 and Beyond
• NCCN Guidelines^® for Antiemesis, Neuroendocrine Tumors, and Soft Tissue Sarcoma Updated
• Push to Understand Basis of Childhood Brain Tumors Leads to a New Treatment Target (St. Jude Children’s Research Hospital)
• CA-125 Change Over Time Shows Promise as Screening Tool for Early Detection of Ovarian Cancer (The University of Texas MD Anderson Cancer Center)
• Estrogen-Lowering Drugs Minimize Surgery in Breast Cancer Patients (Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine)
• Wrinkles Are Scarier Than Skin Cancer For Young Tanners (Robert H. Lurie Comprehensive Cancer Center at Northwestern University)

May 17, 2010 | Volume 2 • Issue 10

• Commentary: NCCN Guidelines^® and Impact on Coverage Policy
• NCCN Presents Recommendations for REMS in Oncology
• Smartphone Use Surges Among Physicians
• NCCN Guidelines^® for Bladder Cancer and Breast Cancer Risk Reduction and the NCCN Compendium^® Chapters for Breast Cancer and Breast Cancer Risk Reduction Updated
• Fox Chase Researchers Identify Early Ovarian Cancers
• Cancer Cells Show Rewired, Fragmented, MicroRNA Networks (The Ohio State Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute)
• Breakthrough Method Predicts Risk of Invasive Breast Cancer (UCSF Helen Diller Family Comprehensive Cancer Center)
• UAB Researchers Find Four Biomarkers Important in Colorectal Cancer Treatment Prognosis

May 3, 2010 | Volume 2 • Issue 9

• Newer Agents in the Treatment of Non-Small Cell Lung Cancer are Gaining Popularity
• Update on the Centers for Medicare and Medicaid Services
• NCCN Compendium^® Chapters for Non-Melanoma Skin Cancers Updated
• Liver Cancer Tougher on Some Than Others (City of Hope Comprehensive Cancer Center)
• Maggie Daley Center for Women's Cancer Care Debuts at Northwestern (Robert H. Lurie Comprehensive Cancer Center of Northwestern University)
• Decoding Tumor Genomes Reveals Clues to Spread of Deadly Breast Cancer That Affects Younger Women, African-Americans (Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine)
• “Vicious Circle” Offers New Acute Leukemia Treatment Target (The Ohio State University Comprehensive Cancer Center – James Cancer Hospital & Solove Research Institute)

April 19, 2010 | Volume 2 • Issue 8

• Commentary: What If!
• Practice Patterns Vary in the Ordering of Molecular Markers in Breast, Colon, and Lung Cancers
• NCCN Compendium^® Chapters for Bone Cancer Updated
• Adolescent Drinking Adds to Risk of Breast Disease, Breast Cancer (Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine)
• New Agent Chokes Off Energy Supply, Kills Cancer Cells (Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute)
• Breast Cancer Patients With BRCA Gene Mutations Are Four Times More Likely to Get Cancer in Opposite Breast (Fred Hutchinson Cancer Research Center)
• Treatment Resistance in Some Cancer Cells May Be Reversible (Massachusetts General Hospital Cancer Center)

April 5, 2010 | Volume 2 • Issue 7

• Clinicians Believe That at Least Half of Their Patients Have Difficulty Paying for Treatment
• China Continues to Consult NCCN for Guidance on Cancer Treatment
• NCCN Guidelines^® Expand Their Reach to Japan
• Major Provisions and Immediate Effects of Health Care Reform
• NCCN Guidelines^® for Breast Cancer and NCCN Compendium^® Chapter for Breast Cancer Updated
• Some Clinical Trials Explicitly Exclude Gay and Lesbian Patients (Fox Chase Cancer Center)
• Huntsman Cancer Institute (HCI) Awarded $12,000,000 to Study Colon Cancer
• Moffitt Cancer Center Receives NCI Grant to Create Bioengineered “Designer” Lymph Nodes with Scripps Florida
• Irritable Bowel Syndrome Patients Not at More Risk of Colon Cancer, Polyps (University of Michigan Comprehensive Cancer Center)

March 22, 2010 | Volume 2 • Issue 6

• Sam Donaldson Named Inaugural Chair of NCCN Foundation Board
• February NCCN Trends™ Survey Explores Practice Patterns in Treating Multiple Myeloma and CLL
• Cancer Care at the End of Life: When is Enough, Enough?
• Experts Highlight Impact of Evidence-Based Practice Guidelines on Cancer Care and Cost
• NCCN Guidelines^® for Bone Cancer, Colon Cancer, and Rectal Cancer Updated
• New Combination of Therapies Prolongs Life (Duke Cancer Institute)
• Common Osteoporosis Drugs Are Associated With a Decrease in the Risk of Breast Cancer (Fred Hutchinson Cancer Research Center)
• New Subtype of Breast Cancer Responds to Targeted Drug (Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine)
• Researchers Discover Brain Tumor's "Grow-or-Go" Switch (Ohio State University Comprehensive Cancer Center – James Cancer Hospital & Solove Research Institute)

March 8, 2010 | Volume 2 • Issue 5

• Risk Evaluation Mitigation Strategy (REMS) for ESAs Will Impact Oncology Practices
• NCCN Notes Continued Success of Oncology Research Program (ORP) in 2009
• Lenalidomide as Maintenance Therapy Added to NCCN Guidelines™ for Multiple Myeloma
• UAB Researchers Link Calorie Intake to Cell Lifespan, Cancer Development
• Enrollment Open for First-Ever Trial Testing Light Therapy for Smoking Cessation (Fox Chase Cancer Center)
• The Other Red Fruit That Can Keep the Doctor Away (City of Hope Comprehensive Cancer Center)
• Johns Hopkins Scientists Develop Personalized Blood Tests for Cancer Using Whole Genome Sequencing

February 22, 2010 | Volume 2 • Issue 4

• NCCN Guidelines^® are Used as Patient Care Model in New UnitedHealthcare Program
• Democrats and Republicans to Attend Health Care Reform Meeting Later This Week
• The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) for Antiemesis Have Been Updated and Published as Version 1.2010
• Finances Linked to Depression in Stage Zero Breast Cancer (The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
• Researchers Discover New Way to Kill Pediatric Brain Tumors (Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital)
• Tea and Exercise May Affect Depression in Breast Cancer Patients (Vanderbilt-Ingram Cancer Center)
• Low Forms of Cyclin E Reduce Breast Cancer Drug's Effectiveness (The University of Texas MD Anderson Cancer Center)

February 08, 2010 | Volume 2 • Issue 3

• NCCN Launches Mobile CME Application for Kidney Cancer
• Survey Data Indicates that Majority of Oncology Clinicians Would Find Comparative Effectiveness Information “Extremely Helpful”
• The NCCN Clinical Practice Guidelines in Oncology^® for Ovarian Cancer and Palliative Care Have Been Updated and Published as Version 1.2010
• Washington University, St. Jude Team to Unravel Genetic Basis of Childhood Cancers (Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine and St. Jude Children's Research Hospital)
• Curing More Cervical Cancer Cases May Be in the Math (Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
• Game-Changing Nanodiamond Discovery for MRI (Robert H. Lurie Comprehensive Cancer Center of Northwestern University)
• Study Details First Successful Use of Expanded Umbilical-Cord Blood Units to Treat Leukemia (Fred Hutchinson Cancer Research Center)

January 25, 2010 | Volume 2 • Issue 2

• Chinese Oncology Leaders Participate in NCCN Global Leadership Exchange Program
• NCCN Member Institution Cancer Researcher Earns Two Federal Stimulus Grants
• The NCCN Clinical Practice Guidelines in Oncology^® for Non-Hodgkin's Lymphomas and Prostate Cancer Have Been Updated and Published as Version 1.2010
• More Accurate Diagnosis for Leading Cancer Killer in Children May Be Possible (Huntsman Cancer Institute at the University of Utah)
• Fox Chase Researchers Find New Method of Fixing Broken Proteins to Treat Genetic Diseases
• Drug That Modifies Gene Activity Could Help Some Older Leukemia Patients (Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine)
• Early Immune Response Needed For Hit-and-Hide Cancer Virus (The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)

January 11, 2010 | Volume 2 • Issue 1

• NCCN Developing Recommendations for Appropriate Use of REMS in Cancer Care
• Ohio State Study Indicates that Amish Populations Have Lower Rates of Cancer
• The NCCN Clinical Practice Guidelines in Oncology^® for Non-Small Cell Lung Cancer Have Been Updated and Published as Version 1.2010
• Cancer, Alzheimer's Less Likely to Strike in Combination (Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine)
• Fox Chase's Hormoz Ehya Inducted as President of the American Society of Cytopathology
• Aggressive Infection Control Program Protects Cancer Patients From Acquiring Clinic-Based H1N1 Influenza (Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance)
• City of Hope Neuroscientists Identify Control Mechanism for Stem Cell Production

December 21, 2009 | Volume 1 • Issue 15

• November NCCN Trends™ Survey Sheds Light on Compendium Use and Uptake of CPOE
• NCCN Oncology Summit on Comparative Effectiveness Gathers Key Stakeholders in Washington, DC
• NCCN Clinical Practice Guidelines in Oncology^® for Breast Cancer Screening and Diagnosis, Senior Adult Oncology, and Small Cell Lung Cancer published as V.1.2010
• Study Links Soy Foods to Lower Risk of Breast Cancer Recurrence and Death (Vanderbilt-Ingram Cancer Center)
• Spices Halt Growth of Breast Stem Cells, U-M Study Finds (University of Michigan Comprehensive Cancer Center)
• Multi-Center Study Reduces Transplant Risk In AML Patients (The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
• Pancreatic Tumors Are Marked for Immune Therapy (Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine)

December 7, 2009 | Volume 1 • Issue 14

• NCCN Trends™ Survey Examines Perceptions of Breast Cancer and Prostate Cancer Screening (Article 2 of 2 in a series)
• NCCN Faculty and Korean Oncologists Meet in Seoul to Revise Korea Editions of NCCN Guidelines
• NCCN Clinical Practice Guidelines in Oncology^® for Breast Cancer Screening and Diagnosis, Senior Adult Oncology, and Small Cell Lung Cancer published as V.1.2010
• Research Sheds Light on Workings of Anti-Cancer Drug (Robert H. Lurie Comprehensive Cancer Center of Northwestern University)
• Moffitt Cancer Center Researchers Recognized For Advances In Radiation Oncology
• Crosstalk Between Critical Cell-Signaling Pathways Holds Clues To Tumor Invasion and Metastasis (The University of Texas MD Anderson Cancer Center)
• Fertility Procedures Need Not Delay Breast Cancer Treatment For Younger Women (Stanford Cancer Institute)

November 23, 2009 | Volume 1 • Issue 13

• NCCN Trends™ Survey Examines Perceptions of Breast Cancer and Prostate Cancer Screening (Article 1 of 2 in a series)
• NCCN Posts Draft White Paper on Comparative Effectiveness in Oncology
• NCCN Clinical Practice Guidelines in Oncology^® for Kidney Cancer Have Been Updated to Incorporate the Recently Approved Therapy Pazopanib as a Treatment Option for Patients with Advanced Renal Cell Carcinoma
• First Report of Using Radiolabeled Antibodies and Stem Cell Transplantation to Successfully Treat Advanced Leukemia (Fred Hutchinson Cancer Research Center)
• Lurie Cancer Center Member will be First Orthopedic Surgeon in Space
• Fox Chase Cancer Center Appoints Massimo Cristofanilli, M.D., F.A.C.P., Chairman of the Department of Medical Oncology
• High-Precision Radiation Therapy Improves Cervical Cancer Outcomes (Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine)

November 9, 2009 | Volume 1 • Issue 12

• Oncology Reimbursement Issues Prompt NCCN to Offer a New Resource at the 2010 Annual Conference – the NCCN Reimbursement Resource Room
• NCCN Member Institution Brings American Cancer Clinic and Training Facility to Africa Through USAID Grant
• Updates Published to Six NCCN Guidelines - Anal Carcinoma, Colorectal Cancer Screening, Distress Management, Hepatobiliary Cancers, Kidney Cancer, and Melanoma
• Vanderbilt NIH Grant Bolsters Search for New Cancer Drugs (Vanderbilt-Ingram Cancer Center)
• Center to Open New Directions for Cancer Research (Robert H. Lurie Comprehensive Cancer Center of Northwestern University)
• Cancer Treatment Guidelines for Diverse Asian Economies Use Model Developed at Fred Hutchinson Cancer Research Center
• Undetectable PSA after Radiation is Possible and Predicts Good Patient Outcomes (Fox Chase Cancer Center)

October 26, 2009 | Volume 1 • Issue 11

• Global Leadership Exchange Program to Bring Oncologists and Administrators from China to NCCN Member Institutions
• UnitedHealthcare Provides Physicians with Free Access to NCCN Drugs & Biologics Compendium^®
• NCCN Clinical Practice Guidelines in Oncology^® for Uterine Neoplasms and Cervical Cancer published as V.1.2010
• New Chromosomal Abnormality Identified in Leukemia Associated with Down Syndrome (St. Jude Children's Research Hospital)
• Detecting the Undetectable in Prostate Cancer Testing (Robert H. Lurie Comprehensive Cancer Center of Northwestern University)
• Study Examines Mastectomy and Breast-Conserving Surgery Rates (University of Michigan Comprehensive Cancer Center and Memorial Sloan-Kettering Cancer Center)
• $16 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative-Effectiveness Research in Cancer (Fred Hutchinson Cancer Research Center)

October 12, 2009  | Volume 1 • Issue 10

• Clinicians Report on Changes in Use of ESAs, Outpatient Blood Transfusions, and Supplemental Iron as Interventions for Anemia
• NCCN/Discovery Health Television Program Living with Advanced Non-Small Cell Lung Cancer to Premiere on October 18
• NCCN Drugs & Biologics Compendium^® for Bladder Cancer published as V.1.2010
• Studies Find Few Risks to Newborn Offspring of Parents Who Are Childhood Cancer Survivors (Fred Hutchinson Cancer Research Center)
• Moffitt Cancer Center Researcher Named President-Elect of The Society For Molecular Imaging
• Exercise Associated with Lower Risk of Prostate Cancer, Less Aggressive Disease (Duke Comprehensive Cancer Center)
• More Women Choosing to Remove Healthy Breast after Cancer Diagnosis (Roswell Park Cancer Institute)

September 28, 2009 | Volume 1 • Issue 9

• Shortages of Leucovorin and Radioisotope Seen to Affect Some Oncology Practices
• NCCN Begins Working with Clinical Care Options on Interactive Educational Tools
• NCCN Clinical Practice Guidelines in Oncology^® for Antiemesis Published as V.4.2009
• Lung Cancer Trial Goes Online for 'Never Smokers' (Vanderbilt-Ingram Cancer Center)
• New Reconstruction Method Makes Speaking, Eating Possible After Tonsil Cancer Surgery, University of Michigan study shows
• Upcoming Biomedical Symposium Attracts World Leaders in Apoptosis Research (St. Jude Children's Research Hospital)
• Doctors Fear Asking Mentally Ill to Quit Smoking (Robert H. Lurie Comprehensive Cancer Center)

September 14, 2009 | Volume 1 • Issue 8

• REMS Web Pages on NCCN.org and NCCN.com Provide Resources for Clinicians and Patients
• NCCN Launches Consumer Medication Information Sheets at Hematologic Malignancies Congress in New York City
• NCCN Clinical Practice Guidelines in Oncology^® for Bladder Cancer, Kidney Cancer, and Testicular Cancer published as V.1.2010
• Study Finds Obesity, Alcohol Consumption and Smoking Increase the Risk of Developing a Second Breast Cancer (Fred Hutchinson Cancer Research Center)
• Researchers create new design for monoclonal antibodies to reduce side effects of cancer treatments and potentially increase effectiveness (The University of Texas MD Anderson Cancer Center)
• Researchers Identify New, Cancer-Causing Role for Protein (The University of Texas MD Anderson Cancer Center)
• New Hope for Deadly Childhood Bone Cancer: Surprising Discovery Made by Studying So-Called "Junk DNA" (Huntsman Cancer Institute at the University of Utah)

August 31, 2009 | Volume 1 • Issue 7

• Updated NCCN.com Summaries Provide Patients with Information to Accompany Professional Guidelines
• More than 700 Managed Care Professionals Attend Online Training from NCCN
• NCCN Clinical Practice Guidelines in Oncology^® for Myelodysplastic Syndromes Updated
• NCCN Clinical Practice Guidelines in Oncology^® for Cancer- and Chemotherapy-Induced Anemia Updated
• Long-Term Tamoxifen Use Increases the Risk of an Aggressive, Difficult to Treat Type of Second Breast Cancer (Fred Hutchinson Cancer Research Center)
• Vanderbilt Joins National Consortium to Develop New Cancer Therapies (Vanderbilt-Ingram Cancer Center)
• Disparities in Cancer Care Reflect Hospital Resources, U-M Study Finds (Univ. of Michigan Comprehensive Cancer Center)
• Low-Dose Estrogen Shown Safe and Effective for Metastatic Breast Cancer (Siteman Cancer Center at Barnes-Jewish Hospital and Washington Univ. School of Medicine)

August 17, 2009 | Volume 1 • Issue 6

• Survey Examines How Clinicians Use NCCN Guidelines
• NCCN Oncology Research Program Using Online Networking Tool in Multi-Institutional Head and Neck Squamous Cell Cancer Study
• NCCN Clinical Practice Guidelines in Oncology^® for Prevention and Treatment of Cancer-Related Infections Updated 
• NCCN Chemotherapy Order Templates^® for Rectal Cancer Published
• Colon Cancer May Yield to Cellular Sugar Starvation (The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)
• Moffitt Cancer Center Involved in Study that Shows Genetic Link to Increased Risk of Ovarian Cancer
• Scientists discover bladder cancer stem cell (Stanford Cancer Institute)
• Fox Chase Researchers Identify Differences in Treatments and Outcomes of Patients with Second Primary Lung Cancers versus those with One Primary Lung Cancer

August 3, 2009 | Volume 1 • Issue 5

• NCCN Engages in Comparative Effectiveness Policy Discussions
• NCCN to Launch Cancer Medication Information for Patients in September 2009
• NCCN Clinical Practice Guidelines in Oncology^® for Prostate Cancer Early Detection Updated
• St. Jude scientists identify new genes implicated in childhood acute myeloid leukemia (AML)
• Moffitt Cancer Center Receives State Grant Money for Cancer Research
• New information about DNA repair mechanism could lead to better cancer drugs (Siteman Cancer Center)
• New Technique Could Save Cancer Patients' Fertility (Robert H. Lurie Comprehensive Cancer Center)

July 20, 2009 | Volume 1 • Issue 4

• Patient Safety and Oral Chemotherapy
• NCCN educates oncology professionals at NCCN Academy for Excellence & Leadership in Oncology™ programs
• Link Between Migraines and Reduced Breast Cancer Risk Confirmed in Follow-up Study (Fred Hutchinson Cancer Research Center)
• Huntsman Cancer Institute Announces Major New Training Initiative for Cancer Research
• "Normal" Cells Far from Cancer Give Nanosignals of Trouble (Robert H. Lurie Comprehensive Cancer Center)
• Mice with skin condition help scientists understand tumor growth (Siteman Cancer Center)

July 6, 2009 | Volume 1 • Issue 3

• NCCN Oncology Research Best Practices Conference to emphasize quality and efficiency in clinical trials operations
• NCCN survey identifies cancer-related fatigue as an area of need for education
• The NCCN Clinical Practice Guidelines in Oncology^® for Multiple Myeloma updated
• Acute lymphoblastic leukemia, the most common childhood cancer, is curable without preventive cranial radiation (St. Jude Children's Research Hospital)
• Study Challenges Routine Use of MRI Scans to Evaluate Breast Cancer (Fox Chase Cancer Center)
• Vanderbilt-Ingram Cancer Center Unveils Stereotactic Radiosurgery Suite
• Congresswoman Castor and Moffitt Cancer Center Announce Infusion of Recovery Act Funding

June 22, 2009 | Volume 1 • Issue 2

• REMS will have implications for oncology practice
• NCCN tool measuring productivity of PA/NPs presented at 2009 ASCO Annual Meeting
• The NCCN Clinical Practice Guidelines in Oncology^® for Chronic Myelogenous Leukemia updated
• NCCN Chemotherapy Order Templates^® for Anal Carcinoma Added to NCCN.org  
• Fox Chase's Eric M. Horwitz Elected President of American Brachytherapy Society
• New Drug in Phase 1 Trial Shows Objective Responses in Metastatic Melanoma Patients
• Researchers find how a common genetic mutation makes cancer radiation resistant
• HCI Researcher Appointed to National Cancer Institute Board

June 8, 2009 | Volume 1 • Issue 1

• Introducing the NCCN eBulletin
• "Cancer is now on the table" – Conversations with Managed Care Executives
• What is the NCCN Drugs & Biologics Compendium?
• Octreotide therapy for asymptomatic patients with recurrent, unresectable carcinoid tumors added to NCCN Clinical Practice Guidelines in Oncology^® for Neuroendocrine Tumors
• NCCN Clinical Practice Guidelines in Oncology^® for Central Nervous System cancers updated
• NCCN Clinical Practice Guidelines in Oncology^® for Venous Thrombolytic Embolism updated
• Everolimus added to NCCN Clinical Practice Guidelines in Oncology^® for Kidney Cancer
• First Robotic Lung Surgery in Tampa Bay Performed at Moffitt Cancer Center
• Small Molecule Inhibitor Shows Promise in Trastuzumab-Resistant Metastatic Breast Cancer
• Technique eradicates problems in most patients with Barrett's esophagus
• PET scan can non invasively measure early assessment of treatment for common type of breast cancer